Current Neuro-Oncology

Volume 28 Number 21
31 July 2026

Home > Publications > Current Neuro-Oncology > Volume 28, Year 2026 > Number 21, 31 July

Lau BC, Ajaero DP, Hoff BA, Pearson A, Sajjakulnukit P, Wadden J, Adam T, Ji S, Green AL, Nabavizadeh A, Cao Y, Aryal M, Upadhyaya S, Franson A, Galban S, Venneti S, Federowicz B, Shapiro MA, Stuhlmiller TJ, Lyssiotis C, Galban CJ, Parmar HA, Ibrahim M, Koschmann C.
Early increase in apparent diffusion coefficient predicts favorable response to Dordaviprone (ONC201) therapy in H3K27M-mutant diffuse midline glioma.
Neuro Oncol. 2026 Jul 21:noag164. doi: 10.1093/neuonc/noag164. PMID: 42482168. ˍ

Liang B, Weil M.
Corticosteroids in Glioblastoma Management: A Reconsideration of a 65-Year Practice.
J Clin Oncol. 2026 Jul 22:JCO2600191. doi: 10.1200/JCO-26-00191. PMID: 42485601. ˍ

Carriere PP, Haisraely O, Aaroe A, Ahmed K, Lewis R, Colson-Fearon D, Bolden M, Swanson TA, Beckham TH, Wang C, De B, Perni S, Tom MC, Li J, McGovern S, McAleer MF, Ghia A, Jiang W, Chung C, Grosshans D, Ballester L, Esquenazi Y, Kamiya-Matsuoka C, Yeboa DN.
Long-term outcomes in IDH-wildtype (IDH-wt) gliomas with historical WHO grade 2 and 3 histology.
J Neurooncol. 2026 Jul 23;179(1):12. doi: 10.1007/s11060-026-05712-2. PMID: 42489814. ˍ

Sanderson E, Drummond K, Dowling A, Bennett I, Freilich R, Phillips C, Ahern E, Campbell D, Campbell R, Harrup R, Reeves S, Collins I, Jennens R, Joshi S, Gan H, Fay M, Lynam J, Lim LE, Rosenthal M, Dumas M, Gibbs P, Gately L.
Salvage therapies for recurrent grade 4 IDH-wildtype glioma: a BRAIN Registry analysis of real-world treatment patterns.
J Neurooncol. 2026 Jul 23;179(1):13. doi: 10.1007/s11060-026-05717-x. PMID: 42493681˰ ˍ

Ronsley R, Huang W, Rohlf E, Seidel K, Brown C, Beebe A, Rawlings-Rhea SD, Lindgren C, Sad T, Crotty EE, Leary SES, Thomsen A, Beckstrom AR, Holtzclaw SL, Hoeppner C, Hurst D, MacQuivey M, Goldstein HE, Browd SR, Hauptman JS, Lee A, Ojemann JG, Wright JN, Albert CM, Pinto N, Gustafson JA, Ho O, Pattabhi S, Summers C, Annesley C, Wendler JN, Gust J, Gardner RA, Park JR, Jensen MC, Vitanza NA.
Intracerebroventricular B7-H3-targeting CAR T cells for non-pontine DMG and recurrent/refractory pediatric CNS tumors: a phase 1 trial.
Neuro Oncol. 2026 Jul 25:noag171. doi: 10.1093/neuonc/noag171. PMID: 42503899. Trial registration ID: NCT04185038˰ ˍ

Alex AT, Hassan SP, Benghiat H, Herbert L, Adamski J, Bailey S, Esler C, Brookes L, Bamber M, Koudou G, Waite K, Bennett J, Das A, Tsang DS.
Re-Irradiation in Pediatric Diffuse Midline Glioma: A Multi-Institutional Retrospective Study.
Pediatr Blood Cancer. 2026 Jul 29:e70498. doi: 10.1002/1545-5017.70498. PMID: 42527894. ˍ

Tu Z, Hu W, Zhang J, Xing Z, Li J, Xu J, Lin M, Jiang X, Cao D, Zhang J, Guo D, Qu X.
Predictions and cross-center validation of IDH status and 1p/19q status in adult diffuse glioma with non-invasive magnetic resonance spectroscopy.
Magn Reson Lett. 2026 Jun 1;7(1):200292. doi: 10.1016/j.mrl.2026.200292. PMID: 42518518. ˍ

Roach JT, Bhakta N, Qaddoumi I, Bouffet E, Robinson GW, Rodriguez-Galindo C, Steliarova-Foucher E, Bray F, Moreira DC.
Global Burden of Pediatric Central Nervous System Tumors.
JAMA Netw Open. 2026 Jul 1;9(7):e2625174. doi: 10.1001/jamanetworkopen.2026.25174. PMID: 42496980. ˍ

Mansouri A, de Macedo Filho L, Tufano E, Laukhuff H, Zacharia B, Neighbors J, Green M, Derosia N, Sun D, Bhanja D, Tuohy K, Connor J, Aregawi DG, Glantz M, Zadeh G.
A phase 0 clinical trial to evaluate the neuropharmacological profile of posaconazole for glioblastoma.
Neurooncol Adv. 2026 Jul 2;8(1):vdag174. doi: 10.1093/noajnl/vdag174. PMID: 42494994. Trial registration ID: NCT04825275. ˍ

Nakata J, Nakamura N, Motooka D, Yokota C, Hayashi Y, Hirayama R, Fujiki F, Morimoto S, Umehara T, Nakajima H, Oji Y, Tsuboi A, Oka Y, Kumanogoh A, Kijima N, Kishima H, Sugiyama H.
Twenty-year persistence of WT1-specific cytotoxic T lymphocytes in peritumoral brain tissue by peptide vaccine therapy: Transcriptomic evidence for resident memory T-cell induction.
Neurooncol Adv. 2026 Jul 9;8(1):vdag176. doi: 10.1093/noajnl/vdag176. PMID: 42494995. ˍ

Vazquez L, Lerch J, Gandra D, Moore A, Lincoln J, Nagulapally AB, Treadway S, Thamburaj K, Brown V, Sholler GS.
Precision medicine directed therapy enabling long-term survival in medulloblastoma: a case report.
Front Oncol. 2026 Jul 14;16:1855992. doi: 10.3389/fonc.2026.1855992. PMID: 42523537. ˍ

Kinslow CJ, Schiff D.
Mature Results from EORTC 22033: Implications of Inferior Results with Monotherapy for Grade 2 Gliomas.
Neuro Oncol. 2026 Jul 20:noag162. doi: 10.1093/neuonc/noag162. PMID: 42477868. ˍ